The shareholders were initially paid Rs 262.80 per share at the time of delisting which worked out to Rs 3,064 crore for the 11.66 crore shares.
CNBC-TV18 learns that the last date for submission of firm bids for Monnet Ispat, which is under the insolvency law, is set for today.
A special report by Grant Thornton suggests that deal activity has picked up pace in November this year. Majority merger and acquisition (M&A) and PE deals are seen in telecom and pharma sector.
IndiGo and Tata Group have already expressed interest in purchasing parts of India's debt-ridden flag carrier.
The company is developing a pipeline of products in child nutrition, an area dominated by multinationals such as Abbott, GSK, Kraft Heinz and Mondelez International.
Mittal said that the debt-ridden Aircel has two options, either to join Vodafone-Idea or go ahead with Airtel.
In a bid to take on competition in a consolidating market, the Sunil Mittal-led company has been buying stressed assets in the telecom sector, and spectrum.
The new plant, which is US FDA compliant, is expected to ease the supply bottlenecks the company is facing.
Axalta has a market capitalization of USD 8.2 billion while Nippon has a market capitalization of 1.2 trillion yen (USD 10.7 billion).
The company had earlier said that it is capable of spending up to USD 1 billion on both capacity expansion and acquisitions, per annum.
In an interview to CNBC-TV18's Ekta Batra and Vikas Dandekar, the Executive Chairman of Torrent Pharma, Samir Mehta spoke about the rationale behind the deal and where it would take the company in the Indian pharmaceutical market.
Torrent Pharmaceuticals will acquire Unichem Laboratories' branded formulation business in India and Nepal for Rs 3,600 crore.
Watch accompanying videos of the Mint Dealmakers Forum 2017 wherein eminent panellist talked about the mergers and acquisition (M&A) over the last one year and what are the effects of these M&A on their business.
Banking sector during the week saw more of disappointing news of job cuts, bad loans and NPA divergences raising questions on bank auditors. Further public sector banks reported losses due to rise in bad loans
The Torrent Pharmaceuticals and Unichem Laboratories deal is close to fruition. On a day this Rs 3600 crore deal has been sealed, it is a good time to look at M&A activity in 2017 so far. In an interview to CNBC-TV18, Raja Lahiri of Grant Thornton, Randhir Kochhar of Ernst & Young, Vivek Gupta of KPMG and Ashvin Parekh of Ashvin Parekh Advisory Services discussed about the same.
Torrent will fund the acquisition through a mix of internal accruals and bank borrowings.
R Thyagarajan of Shriram Group said both parties can explore the merger without the pressure of the exclusivity period.
Based on a sum of parts analysis, IDFC shareholders pegged the company's fair value at Rs 16,700 crore, which translates to roughly Rs 104 per share.
In the same quarter last year, the country had recorded investments of USD 2.56 billion across 243 deals
The combined company is expected to have 2017 pro forma net revenue ranging from USD 1.75 billion to USD 1.85 billion and pro forma adjusted EBITDA of approximately USD 600 million to USD 650 million in 2017 and USD 700 million to USD 750 million in 2018, each including USD 80 million to USD 120 million of annualized cost savings within the first full year of close.
IndusInd Bank on Saturday confirmed its acquisition of microfinance institution Bharat Financial Inclusion after over a month of exclusive merger arrangement. In an interview to CNBC-TV18, Digant Haria of Antique Stock Broking and Santosh Singh of Haitong Securities shared their views and reading on the deal and the stocks.
IndusInd Bank on Saturday confirmed its acquisition of microfinance institution Bharat Financial Inclusion after over a month of exclusive merger arrangement. CNBC-TV18's Kevin Lee caught up with Bharat Financial's MD & CEO, MR Rao.
The life insurer had reported profit of Rs 300 crore last fiscal. The overall networth of the business stood at Rs 1,825 crore as of March 2017.
The wave of consolidation continues in the telecom space. Tata Teleservices (Maharashtra) will merge with India's top service provider Bharti Airtel in a "debt-free" and "cash-free" deal.
Lupin on Wednesday has agreed to buy US-based Symbiomix Therapeutics for USD 150 million. The drug maker will be doing several deals in the coming quarters.